4//SEC Filing
Hamel Lawrence G 4
Accession 0001209191-19-015617
CIK 0001427925other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:24 PM ET
Size
5.5 KB
Accession
0001209191-19-015617
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Purchase
Common Stock
2019-02-28$2.81/sh+3,682$10,346→ 78,053 total
Holdings
- 29,795(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Balance includes non-reportable acquisition of 3,682 shares of Common Stock through the Company's Employee Stock Purchase Plan.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001511368
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:24 PM ET
- Size
- 5.5 KB